ZYNE

Zynerba Pharmaceuticals, Inc.

1 day chart

About ZYNE

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Buy US stocks in Australia starting with ZYNE. Open an account and start investing today!

Market Capitalisation

$17.65M

Price-earnings ratio

Dividend yield

0.00%

Volume

681.86K

High today

$0.37

Low today

$0.31

Open price

$0.33

52-week high

$1.60

52-week low

$0.30

ZYNE FAQs

Can I buy ZYNE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy ZYNE shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Zynerba Pharmaceuticals, Inc.?

One share of Zynerba Pharmaceuticals, Inc. is valued at $0.34.

What is the ticker symbol for Zynerba Pharmaceuticals, Inc.?

The ticker symbol for Zynerba Pharmaceuticals, Inc. is ZYNE.

How do I buy ZYNE shares in Australia?

To buy ZYNE stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ZYNE

What is the 52-week high for Zynerba Pharmaceuticals, Inc. stock?

The Zynerba Pharmaceuticals, Inc. 52-week high stock price is $1.60.

What is the 52-week low for Zynerba Pharmaceuticals, Inc. stock?

The Zynerba Pharmaceuticals, Inc. 52-week low stock price is $0.30.

What is the market capitalisation of Zynerba Pharmaceuticals, Inc. ZYNE?

As of 31/05/2023 Zynerba Pharmaceuticals, Inc. has a market cap of $18M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.